Assembly Biosciences Inc. | Mutual Funds
Mutual Funds that own Assembly Biosciences Inc.
Prudential Jennison Health Sciences Fund
1,579,048
6.21%
0
2.48%
07/31/2018
Vanguard Total Stock Market Index Fund
553,090
2.17%
124,900
0%
07/31/2018
Janus Global Life Sciences Fund
359,997
1.42%
105,169
0.35%
06/30/2018
iShares Russell 2000 ETF
355,403
1.4%
-189
0.03%
09/06/2018
Vanguard Extended Market Index Fund
276,050
1.09%
47,799
0.02%
07/31/2018
Fidelity Select Biotechnology Portfolio
187,700
0.74%
125,700
0.08%
07/31/2018
iShares Russell 2000 Growth ETF
162,269
0.64%
0
0.06%
09/06/2018
Hartford Healthcare Fund
158,100
0.62%
158,100
0.4%
07/31/2018
AXA Framlington Biotech Fund
116,936
0.46%
0
0.66%
02/28/2018
Fidelity Spartan Extended Market Index Fund
93,886
0.37%
16,387
0.02%
07/31/2018
| Address |
11711 North Meridian Street
Carmel Indiana 46032
United States
|
|
Employees
|
- |
| Website |
http://www.assemblybio.com |
| Updated |
07/08/2019 |
| Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN. |
